Euthoxin 500 mg/ml solution for injection
Euthoxin 500 mg/ml solution for injection
Authorised
- Pentobarbital sodium
- Pentobarbital sodium
- Pentobarbital sodium
- Pentobarbital sodium
Product identification
Medicine name:
Euthoxin 500 mg/ml solution for injection
Euthoxin 500 mg/ml Oplossing voor injectie
Euthoxin 500 mg/ml Solution injectable
Euthoxin 500 mg/ml Injektionslösung
Active substance:
- Pentobarbital sodium
- Pentobarbital sodium
- Pentobarbital sodium
- Pentobarbital sodium
Target species:
-
Dog
-
Cat
-
Mink
-
Ferret
-
Hare
-
Rabbit
-
Guinea pig
-
Hamster
-
Rat
-
Chicken
-
Homing pigeon
-
Ornamental bird
-
Snake
-
Turtle
-
Lizard
-
Frog
-
Horse
-
Cattle
-
Pig
-
Dog
-
Cat
-
Mink
-
Ferret
-
Hare
-
Rabbit
-
Guinea pig
-
Hamster
-
Rat
-
Chicken
-
Homing pigeon
-
Ornamental bird
-
Snake
-
Turtle
-
Lizard
-
Frog
-
Horse
-
Cattle
-
Pig
-
Dog
-
Cat
-
Mink
-
Ferret
-
Hare
-
Rabbit
-
Guinea pig
-
Hamster
-
Rat
-
Chicken
-
Homing pigeon
-
Ornamental bird
-
Snake
-
Turtle
-
Lizard
-
Frog
-
Horse
-
Cattle
-
Pig
-
Dog
-
Cat
-
Mink
-
Ferret
-
Hare
-
Rabbit
-
Guinea pig
-
Hamster
-
Rat
-
Chicken
-
Homing pigeon
-
Ornamental bird
-
Snake
-
Turtle
-
Lizard
-
Frog
-
Horse
-
Cattle
-
Pig
Route of administration:
-
Intravenous use
-
Intracardiac use
-
Intraperitoneal use
-
Intrapulmonary use
Product details
Active substance and strength:
-
Pentobarbital sodium500.00/milligram(s)1.00millilitre(s)
-
Pentobarbital sodium500.00/milligram(s)1.00millilitre(s)
-
Pentobarbital sodium500.00/milligram(s)1.00millilitre(s)
-
Pentobarbital sodium500.00/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QN51AA01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- 100 ml Type I amber multi-dose glass vials closed with a bromobutyl rubber stopper and sealed with an aluminium overseal. The product is presented in a carton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V520160
Date of authorisation status change:
Reference member state:
-
Portugal
Procedure number:
- PT/V/0142/001
Concerned member states:
-
Austria
-
Belgium
-
Croatia
-
France
-
Greece
-
Hungary
-
Ireland
-
Netherlands
-
Norway
-
Romania
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 19/05/2025
Labelling
This document does not exist in this language (English). You can find it
in another language below.